Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Nehmiz · SciRah

Researcher profile · Semantic Scholar

G. Nehmiz

Share profile

G. Nehmiz — researcher profile on SciRah

h-index: 24
Works: 55
Citations: 3,873

Most-cited papers

The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).
P. Reilly, T. Lehr, S. Haertter, S. Connolly +6 more
2014Journal of the American College of Cardiology875 citations Open access
Semantic Scholar
Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).
M. Ezekowitz, P. Reilly, G. Nehmiz, Timothy A. Simmers +6 more
2007American Journal of Cardiology462 citations
Semantic Scholar
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.
H. Hinrichsen, Y. Benhamou, H. Wedemeyer, M. Reiser +9 more
2004Gastroenterology351 citations Open access
Semantic Scholar
Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement
J. Stangier, B. Eriksson, O. Dahl, L. Ahnfelt +4 more
2005Journal of clinical pharmacology309 citations
Semantic Scholar
Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I
B. Eriksson, O. Dahl, L. Ahnfelt, P. Kälebo +4 more
2004Journal of Thrombosis and Haemostasis233 citations Open access
Semantic Scholar
Antiviral efficacy of NS3‐serine protease inhibitor BILN‐2061 in patients with chronic genotype 2 and 3 hepatitis C
M. Reiser, H. Hinrichsen, Y. Benhamou, H. Reesink +6 more
2005Hepatology184 citations Open access
Semantic Scholar
Oral bioavailability of dabigatran etexilate (Pradaxa(®) ) after co-medication with verapamil in healthy subjects.
S. Härtter, R. Sennewald, G. Nehmiz, P. Reilly
2013British Journal of Clinical Pharmacology175 citations Open access
Semantic Scholar
Empagliflozin (BI 10773), a Potent and Selective SGLT2 Inhibitor, Induces Dose‐Dependent Glucosuria in Healthy Subjects
L. Seman, S. Macha, G. Nehmiz, G. Simons +4 more
2013Clinical pharmacology in drug development137 citations
Semantic Scholar
Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin.
S. Härtter, Michael Koenen-Bergmann, Ashish Sharma, G. Nehmiz +3 more
2012British Journal of Clinical Pharmacology127 citations Open access
Semantic Scholar
Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection.
S. Zeuzem, T. Asselah, P. Angus, J. Zarski +16 more
2011Gastroenterology127 citations Open access
Semantic Scholar
Faldaprevir combined with pegylated interferon alfa‐2a and ribavirin in treatment‐naïve patients with chronic genotype1 HCV: SILEN‐C1 trial
M. Sulkowski, T. Asselah, J. Lalezari, P. Ferenci +12 more
2013Hepatology114 citations Open access
Semantic Scholar
Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo.
Thomas H. Müller, C.-A.-P.-F. Su, H. Weisenberger, R. Brickl +2 more
1990British Journal of Clinical Pharmacology81 citations Open access
Semantic Scholar
Faldaprevir combined with peginterferon alfa‐2a and ribavirin in chronic hepatitis C virus genotype‐1 patients with prior nonresponse: SILEN‐C2 trial
Mark S. Sulkowski, M. Bourlière, J. Bronowicki, T. Asselah +12 more
2013Hepatology75 citations Open access
Semantic Scholar
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment
A. Erhardt, K. Deterding, Y. Benhamou, M. Reiser +16 more
2009Antiviral Therapy71 citations
Semantic Scholar
Effect of Food on the Pharmacokinetics of Meloxicam after Oral Administration
D. Türck, U. Busch, G. Heinzel, H. Narjes +1 more
199544 citations
Semantic Scholar
Interaction of Meloxicam with Cimetidine, Maalox, or Aspirin
U. Busch, Gunther Heinzel, H. Narjes, G. Nehmiz
1996Journal of clinical pharmacology42 citations
Semantic Scholar
60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION
M. Sulkowski, E. Ceasu, T. Asselah, F. Căruntu +15 more
201140 citations
Semantic Scholar
1054 SAFETY, PHARMACOKINETICS AND ANTIVIRAL EFFECT OF BI 207127, A NOVEL HCV RNA POLYMERASE INHIBITOR, AFTER 5 DAYS ORAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C
A. Erhardt, H. Wedemeyer, Y. Benhamou, C. Moellekens +13 more
200736 citations
Semantic Scholar
136 Antiviral effect of BILN 2061, a novel HCV serine protease inhibitor, after oral treatment over 2 days in patients with chronic hepatitis C, non-genotype 1
M. Reiser, H. Hinrichsen, Y. Benhamou, R. Sentjens +6 more
200336 citations
Semantic Scholar
Faldaprevir (Bi 201335), Deleobuvir (Bi 207127) and Ribavirin Oral Therapy for Treatment-Naive HCV Genotype 1: Sound-C1 Final Results
S. Zeuzem, T. Asselah, P. Angus, J. Zarski +16 more
2013Antiviral Therapy35 citations
Semantic Scholar
Mechanisms Underlying Benign and Reversible Unconjugated Hyperbilirubinemia Observed with Faldaprevir Administration in Hepatitis C Virus Patients
R. Sane, G. Steinmann, Qi-Hong Huang, Yongmei Li +9 more
2014Journal of Pharmacology and Experimental Therapeutics34 citations Open access
Semantic Scholar
Pharmacokinetics and tolerability of meloxicam after i.m. administration.
H. Narjes, D. Türck, U. Busch, G. Heinzel +1 more
1996British Journal of Clinical Pharmacology31 citations Open access
Semantic Scholar
Viral Kinetics in Patients with Chronic Hepatitis C Treated with the Serine Protease Inhibitor Biln 2061
E. Herrmann, S. Zeuzem, C. Sarrazin, H. Hinrichsen +8 more
2005Antiviral Therapy30 citations Open access
Semantic Scholar
Long-term efficacy and safety of Pimobendan in moderate heart failure: A double-blind parallel 6-month comparison with enalapril
W. Remme, H. Krayenbühl, G. Baumann, M. Frick +3 more
199425 citations
Semantic Scholar
Effect of hospitalisation on liver enzymes in healthy subjects
H. Narjes, G. Nehmiz
2000European Journal of Clinical Pharmacology24 citations
Semantic Scholar
Antiviral Effect, Safety, and Pharmacokinetics of Five-Day Oral Administration of Deleobuvir (BI 207127), an Investigational Hepatitis C Virus RNA Polymerase Inhibitor, in Patients with Chronic Hepatitis C
D. Larrey, A. Lohse, C. Trépo, J. Bronowicki +10 more
2013Antimicrobial Agents and Chemotherapy23 citations Open access
Semantic Scholar
1236 MECHANISMS OF ISOLATED UNCONJUGATED HYPERBILIRUBINEMIA INDUCED BY THE HCV NS3/4A PROTEASE INHIBITOR BI201335
R. Sane, Lalitha Podila, A. Mathur, K. Mease +5 more
201121 citations Open access
Semantic Scholar
Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study.
K. Akkerhuis, K. Neuhaus, R. G. Wilcox, A. Vahanian +8 more
2000European Heart Journal20 citations Open access
Semantic Scholar
Meloxicam pharmacokinetics in renal impairment.
J. Boulton-Jones, C. G. Geddes, G. Heinzel, D. Türck +2 more
1997British Journal of Clinical Pharmacology18 citations
Semantic Scholar
Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects.
B. Guth, H. Narjes, H. Schubert, P. Tanswell +2 more
2004British Journal of Clinical Pharmacology17 citations Open access
Semantic Scholar
Abstract 4629: Long-Term Open Label Extension of the Prevention of Embolic and Thrombotic Events on Dabigatran in Atrial Fibrillation (PETRO- Ex study)
R. Nagarakanti, M. Ezekowitz, Kambiz Parcham-Azad, P. Reilly +3 more
200814 citations
Semantic Scholar
Bayesian Phase II optimization for time-to-event data based on historical information
A. Bertsche, F. Fleischer, J. Beyersmann, G. Nehmiz
2019Statistical Methods in Medical Research9 citations Open access
Semantic Scholar
Precision of measurement of tissue concentrations by RLG.
U. Busch, Gunther Heinzel, G. Nehmiz
2000Regulatory toxicology and pharmacology : RTP9 citations
Semantic Scholar
Efficacy and duration of action of three doses of Zatebradine (ULFS 49 CL) in patients with chronic angina pectoris compared to placebo
W. Baiker, E. Czakó, M. Keck, G. Nehmiz
19919 citations
Semantic Scholar
Review article: HCV ? STAT-C era of therapy
C. Lange, Chris Sarrazin, S. Zeuzem, M. Fried +496 more
20108 citations
Semantic Scholar
294 Safety and antiviral effect of BILN 2061, a novel HCV serine protease inhibitor, after oral treatment over 2 days in patients with chronic hepatitis C, genotype 1, and liver cirrhosis
H. Wedemeyer, A. Erhardt, W. Schmiegel, H. Hinrichsen +5 more
20037 citations
Semantic Scholar
67 Hepatitis C viral kinetics in chronically infected patients treated with the serine protease inhibitor BILN 2061
E. Herrmann, S. Zeuzem, C. Sarrazin, H. Hinrichsen +4 more
20045 citations Open access
Semantic Scholar
[Acute and long-term effects of pimobendan (UD-CG 115) in NYHA II and III heart failure. Results of a randomized multicenter double-blind study].
I. Assmann, P. Kassel, H. Duck, H. Fiehring +4 more
1991Zeitschrift für Kardiologie5 citations
Semantic Scholar
An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery.
B. Eriksson, Zsolt Mikuska, M. Feuring, J. Amiral +4 more
2016Thrombosis Research4 citations
Semantic Scholar
1185 CHARACTERIZATION OF HCV NS3 VARIANTS THAT EMERGED DURING VIROLOGIC BREAKTHROUGH AND RELAPSE FROM BI 201335 PHASE II SILEN-C2 STUDY IN PEGIFN/RBV TREATMENT-EXPERIENCED PATIENTS
G. Kukolj, R. Bethell, M. Cartier, A. Côté-Martin +13 more
20124 citations
Semantic Scholar
Effect of zatebradine, a novel 'sinus node inhibitor', on pulmonary function compared to placebo.
F. Maesen, J. Smeets, J. van Noord, G. Nehmiz +2 more
1994Pulmonary Pharmacology3 citations
Semantic Scholar
Long-term efficacy and safety of pimobendan in moderate heart failure. A double-blind parallel 6-month comparison with enalapril. The Pimobendan-Enalapril Study Group.
W. Remme, H. Krayenbühl, G. Baumann, M. Frick +3 more
1994European Heart Journal2 citations
Semantic Scholar
Lactate and pyruvate kinetics after treadmill exercise in patients with intermittent claudication.
U. Maass, B. Goller, R. Grote, K. Alexander +2 more
1989VASA. Zeitschrift fur Gefasskrankheiten2 citations
Semantic Scholar
Joint bayesian network meta-analysis for event counts and hazards – comparison of methods and implementations
H. Schmidt, G. Nehmiz
20141 citations Open access
Semantic Scholar
Quantitative quality assessment during the pharmaceutical process design stage taking into account prior expert knowledge
A. Bertsche, G. Nehmiz, M. Brendel
20180 citations
Semantic Scholar
The predictive distribution of the residual variability in the linear‐fixed effects model for clinical cross‐over trials
A. Bertsche, G. Nehmiz, J. Beyersmann, Andrew P. Grieve
2016Biometrical journal. Biometrische Zeitschrift0 citations
Semantic Scholar
A practical GLMM example: Network meta-analysis of studies of binary outcomes – occurrence of exacerbations in COPD patients
H. Schmidt, G. Nehmiz
20150 citations
Semantic Scholar
Chronic Hepatitis C Polymerase Inhibitor, in Patients with an Investigational Hepatitis C Virus RNA Administration of Deleobuvir (BI 207127), Pharmacokinetics of Five-Day Oral Antiviral Effect, Safety, and
G. Kukolj, K. L. Berger, M. Marquis, J. Stern +4 more
20140 citations
Semantic Scholar
Clinical Pharmacology in Drug Development Offi cial Publication of the American College of Clinical Pharmacology
C. Shaefer, A. Digenio, A. Vlajnic, R. Zhou +19 more
20130 citations
Semantic Scholar
Introduction to Bayesian non-parametric survival analysis
G. Nehmiz
20130 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Stern×13
Invite
J. Stern — researcher profile on SciRah
G. Steinmann×12
Invite
G. Steinmann — researcher profile on SciRah
G. Kukolj×10
Invite
G. Kukolj — researcher profile on SciRah
Y. Benhamou×8
Invite
Y. Benhamou — researcher profile on SciRah

×7

Invite

H. Hinrichsen — researcher profile on SciRah

H. Wedemeyer×7

Invite

H. Wedemeyer — researcher profile on SciRah

Invite

T. Asselah — researcher profile on SciRah

Invite

W. Böcher — researcher profile on SciRah

Invite

M. Reiser — researcher profile on SciRah

Invite

J. Calleja — researcher profile on SciRah

Invite

X. Forns — researcher profile on SciRah

Invite

D. Larrey — researcher profile on SciRah